NUEVOCOR
HQ - Singapore
Summary
Nuevocor is a preclinical-stage biopharmaceutical company based in Singapore that is focused on developing gene therapy-based treatments for cardiovascular diseases, specifically genetic cardiomyopathies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 34 M
Avg. Deal Size£ 34 M
All rights reserved. Copyright © 2025 Datasite
